CF Stock Recent News

CF benefits from healthy global demand for nitrogen fertilizers backed by supportive agricultural fundamentals and lower natural gas costs.

CF (CF) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CF Industries (CF) Shares of fertilizer producer CF rose nearly 500% between their 2020 low to their 2022 peak.

RBC analysts have tipped uranium, base and precious metals miners to have a strong year as diversified and fertilizer producers face mixed fortunes. Each sector bagged an ‘overweight' rating by analysts from the bank, on strong prospects for the likes of copper and gold, alongside tightness in the uranium market.

CF benefits from the rising global demand for nitrogen fertilizers driven by significant agricultural demand.

SAN DIEGO--(BUSINESS WIRE)---- $ARCT #ClinicalTrial--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today announced that the first CF and OTC deficiency participants initiated dosing in December 2024, in the Company's Phase 2 multiple ascending dose studies. Each participant in the Phase 2 CF study (NCT06747858) is expected t.

HY, ERIC and CF made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 18, 2024.

LGTY, CF and AEM made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 15, 2024.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

CF presents a compelling investment case backed by favorable nitrogen demand fundamentals, rising earnings estimates and an attractive valuation.